Last reviewed · How we verify

Winstrol — Competitive Intelligence Brief

Winstrol (STANOZOLOL) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: stanozolol. Area: Neuroscience.

marketed stanozolol Estrogen receptor Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Winstrol (STANOZOLOL).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Winstrol TARGET STANOZOLOL marketed stanozolol Estrogen receptor 1962-01-01
Orserdu ELACESTRANT Stemline Therap marketed Estrogen Receptor Antagonist [EPC] Estrogen receptor 2023-01-01
Nextstellis ESTETROL Mayne Pharma marketed Estrogen Estrogen receptor 2021-01-01
Cerianna FLUOROESTRADIOL F-18 GE HealthCare marketed Radioactive Diagnostic Agent [EPC] Estrogen receptor 2020-01-01
Osphena OSPEMIFENE Duchesnay marketed Estrogen Agonist/Antagonist [EPC] Estrogen receptor beta 2013-01-01
Duavee conjugated-estrogens-bazedoxifene Pfizer marketed Estrogen [EPC] estrogen receptors α and β 2013-01-01
Duavee BAZEDOXIFENE Wyeth Pharms Pfizer marketed Estrogen [EPC] estrogen receptors (ER) α and β 2013-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (stanozolol class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Winstrol — Competitive Intelligence Brief. https://druglandscape.com/ci/stanozolol. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: